Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

October 1988

Volume 537 The Mesocorticolimbic Dopamine System

Pages xi–xii, 1–537

    1. Preface (pages xi–xii)

      PETER W. KALIVAS and CHARLES B. NEMEROFF

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42092.x

  1. PART I. ANATOMY AND ELECTROPHYSIOLOGY

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Topographic Organization of Ascending Dopaminergic Projections (pages 1–9)

      JAMES H. FALLON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42093.x

    2. Telencephalic Projections of the A8 Dopamine Cell Group (pages 27–50)

      ARIEL Y. DEUTCH, MENEK GOLDSTEIN, FRANK BALDINO JR and ROBERT H. ROTH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42095.x

    3. Influence of Dopamine on Limbic Inputs to the Nucleus Accumbens (pages 86–100)

      G. J. MOGENSON, C. R. YANG and C. Y. YIM

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42098.x

    4. Influence of the Mesocortical/Prefrontal Dopamine Neurons on Their Target Cells (pages 101–111)

      A. M. THIERRY, J. MANTZ, C. MILLA and J. GLOWINSKI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42099.x

  2. PART II. NEUROCHEMICAL PROPERTIES

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Stress and the Mesocorticolimbic Dopamine Systems (pages 138–147)

      ROBERT H. ROTH, SEE-YING TAM, YOSHISHIGE IDA, JING-XIA YANG and ARIEL Y. DEUTCH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42102.x

    2. Neurotoxicity in Dopamine and 5-Hydroxytryptamine Terminal Fields: A Regional Analysis in Nigrostriatal and Mesolimbic Projections (pages 161–172)

      L. S. SEIDEN, D. L. COMMINS, G. VOSMER, K. AXT and G. MAREK

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42104.x

    3. The Biochemistry and Pharmacology of Mesoamygdaloid Dopamine Neurons (pages 173–187)

      CLINTON D. KILTS, CARL M. ANDERSON, TIMOTHY D. ELY and RICHARD B. MAILMAN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42105.x

  3. Preface

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Stress-Related Activation of Cerebral Dopaminergic Systems (pages 188–205)

      ADRIAN J. DUNN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42106.x

  4. PART III. BEHAVIORAL PROPERTIES

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Mesocorticolimbic Dopamine Systems and Reward (pages 206–215)

      H. C. FIBIGER and A. G. PHILLIPS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42107.x

    2. The Functional Output of the Mesolimbic Dopamine System (pages 216–227)

      GEORGE F. KOOB and NEAL R. SWERDLOW

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42108.x

    3. Psychomotor Stimulant Properties of Addictive Drugs (pages 228–234)

      ROY A. WISE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42109.x

    4. Mesencephalic Dopaminergic Neurons: Role in the General Economy of the Brain (pages 235–253)

      HERVÉ SIMON and MICHEL LE MOAL

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42110.x

    5. Relationships between Mesolimbic Dopamine Function and Eating Behavior (pages 254–261)

      GERARD P. SMITH and LINDA H. SCHNEIDER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42111.x

    6. Stress and Enhanced Dopamine Utilization in the Frontal Cortex: The Myth and the Reality (pages 262–272)

      SEYMOUR M. ANTELMAN, STEVEN KNOPF, ANTHONY R. CAGGIULA, DONNA KOCAN, DONALD T. LYSLE and DAVID J. EDWARDS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42112.x

  5. PART IV. CLINICAL MEDICINE (I)

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Neuropeptides, Dopamine, and Schizophrenia (pages 273–291)

      CHARLES B. NEMEROFF and GARTH BISSETTE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42113.x

    2. Dopamine Receptor Sensitivity Changes with Chronic Stimulants (pages 324–329)

      TONG H. LEE, EVERETT H. ELLINWOOD JR. and J. KEN NISHITA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42116.x

  6. Part IV. Clinical Medicine (I)

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Mesocortical Dopaminergic Function and Human Cognition (pages 330–338)

      DANIEL R. WEINBERGER, KAREN FAITH BERMAN and THOMAS N. CHASE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42117.x

    2. Plasma Homovanillic Acid as an Index of Central Dopaminergic Activity: Studies in Schizophrenic Patients (pages 339–346)

      DAVID PICKAR, ALAN BREIER and JOHN KELSOE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42118.x

  7. PART V. CO-LOCALIZATION AND INTERACTIONS

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Interactions between Mesolimbic Dopamine Neurons, Cholecystokinin, and Neurotensin: Evidence Using in Vivo Voltammetry (pages 347–361)

      ANTHONY G. PHILLIPS, CHARLES D. BLAHA, HANS C. FIBIGER and ROSS F. LANE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42119.x

  8. Part V. Co-localization and Interactions

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Modulation of Mesolimbic Dopaminergic Behaviors by Cholecystokinin (pages 380–396)

      JACQUELINE N. CRAWLEY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42121.x

    2. Neurotensin and the Mesocorticolimbic Dopamine System (pages 397–404)

      GARTH BISSETTE and CHARLES B. NEMEROFF

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42122.x

    3. Enkephalin Modulation of A10 Dopamine Neurons: A Role in Dopamine Sensitization (pages 405–414)

      PETER W. KALIVAS, PATRICIA DUFFY, ROGER DILTS and RAYMOND ABHOLD

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42123.x

  9. PART VI. CLINICAL MEDICINE (II)

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Dopamine Neuronal Tracts in Schizophrenia: Their Pharmacology and in Vivo Glucose Metabolism (pages 443–450)

      CAROL A. TAMMINGA, G. HOWARD BURROWS, THOMAS N. CHASE, LARRY D. ALPHS and GUNVANT K. THAKER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42126.x

    2. MPTP Effects on Dopamine Neurons (pages 451–461)

      IRWIN J. KOPIN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42127.x

    3. The Roles of Glucocorticoid and Dopaminergic Systems in Delusional (Psychotic) Depression (pages 462–471)

      ALAN F. SCHATZBERG and ANTHONY J. ROTHSCHILD

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42128.x

  10. PART VII. POSTER PAPERS

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Localization of Mu Opioid and Neurotensin Receptors within the A10 Region of the Rat (pages 472–474)

      R. P. DILTS and P. W. KALIVAS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42129.x

  11. Part VII. Poster Papers

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface
    1. Effects of Neurotensin on Dopamine Release in the Nucleus Accumbens: Comparisons with Atypical Antipsychotic Drug Action (pages 478–480)

      CHARLES D. BLAHA, ANTHONY G. PHILLIPS, HANS C. FIBIGER and ROSS F. LANE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42131.x

    2. In Situ Hybridization Histochemistry of Tyrosine Hydroxylase Messenger RNA in Rat Brain (pages 484–487)

      FRANK BALDING Jr., ARIEL Y. DEUTCH, ROBERT H. ROTH and MICHAEL E. LEWIS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42133.x

    3. Neurotensin Stimulates the Phosphorylation of Caudate Nucleus Synaptosomal Proteins (pages 488–490)

      SCOTT T. CAIN, MURRAY ABRAMSON and CHARLES B. NEMEROFF

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42134.x

    4. Facilitory and Inhibitory Effects of Nucleus Accumbens Amphetamine on Feeding (pages 491–492)

      LOIS M. COLLE and ROY A. WISE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42135.x

    5. Regulation of Mesolimbic Dopamine Tracts by Cyclo(Leu-GIy) (pages 498–499)

      J. Z. FIELDS, R. SAMI, J. M. LEE, F. DELEON-JONES and R. F. RITZMANN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42138.x

    6. Anatomically Selective Action of Atypical Neuroleptics on the Mesocorticolimbic Dopamine System (pages 502–504)

      ELIOT L. GARDNER and THOMAS F. SEEGER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42140.x

    7. Microdialysis in the Nucleus Accumbens during Feeding or Drugs of Abuse: Amphetamine, Cocaine, and Phencyclidine (pages 508–511)

      LUIZ HERNANDEZ, FRANCIS LEE and HARTLEY G. HOEBEL

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42142.x

    8. Alterations in Neurotensin- and Bombesin-like Immunoreactivity in MPTP-Treated Mice (pages 515–517)

      BETH LEVANT, GARTH BISSETTE, YUKA-MARIE PARKER and CHARLES B. NEMEROFF

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42144.x

    9. Neuropsychological Correlates of Early Parkinson's Disease: Evidence for Frontal Lobe Dysfunction (pages 518–519)

      BONNIE E. LEVIN, MARIA M. LLABRE and WILLIAM J. WEINER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42145.x

    10. Rat Mesocortical Dopaminergic Neurons Are Mixed Neurotensin/Dopamine Neurons: Immunohistochemical and Biochemical Evidence (pages 531–533)

      J. P. TASSIN, P. KITABGI, G. TRAMU, J. M. STUDLER, D. HERVÉ, F. TROVERO and J. GLOWINSKI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb42150.x

  12. Preface

    1. Top of page
    2. PART I. ANATOMY AND ELECTROPHYSIOLOGY
    3. PART II. NEUROCHEMICAL PROPERTIES
    4. Preface
    5. PART III. BEHAVIORAL PROPERTIES
    6. PART IV. CLINICAL MEDICINE (I)
    7. Part IV. Clinical Medicine (I)
    8. PART V. CO-LOCALIZATION AND INTERACTIONS
    9. Part V. Co-localization and Interactions
    10. PART VI. CLINICAL MEDICINE (II)
    11. PART VII. POSTER PAPERS
    12. Part VII. Poster Papers
    13. Preface

SEARCH

SEARCH BY CITATION